Skip to main content
Erschienen in: Tumor Biology 1/2014

01.01.2014 | Research Article

Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis

verfasst von: Qiao-Hui Chen, Qing-Bing Wang, Bei Zhang

Erschienen in: Tumor Biology | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Common functional polymorphisms in the promoter region of microRNAs (miRNAs), based on multiple lines of evidence, might participate in transcriptional regulation and other biological processes, which interact to increase the risk of developing breast cancer. Since 2005, many studies have investigated the association between breast cancer risk and common single nucleotide polymorphisms (SNPs) in miRNAs. However, the findings of several meta-analyses are inconclusive or ambiguous. The aim of this Human Genome Epidemiology meta-analysis was to determine more precisely the relationship between common miRNA polymorphisms and breast cancer risk. Twelve case–control studies with a total of 7,170 breast cancer patients and 8,783 healthy controls were included. Eight SNPs in miRNA genes were examined. When all eligible studies were pooled in the meta-analysis, the miR-196a-2 rs11614913*T, miR-499 rs3746444*T, and miR-605 rs2043556*A alleles predicted a decreased risk of breast cancer among Asians, while not Caucasians. In addition, the miR-27a rs895919*C allele might be a protective factor for breast cancer among Caucasians. However, for the miR-146a rs2910164 (G>C), miR-149 rs2292832 (G>T), miR-373 rs12983273 (C>T), and miR-423 rs6505162 (C>A) polymorphisms, we failed to find any significant association with the risk of breast cancer in any genetic model. In conclusion, the current meta-analysis supports that the miR-196a-2 rs11614913*T, miR-499 rs3746444*T, miR-605 rs2043556*A, and miR-27a rs895919*C alleles might be protective factors for breast cancer.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRef
2.
Zurück zum Zitat McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22:2349–57.PubMedCrossRef McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22:2349–57.PubMedCrossRef
3.
Zurück zum Zitat Stuckey A. Breast cancer: epidemiology and risk factors. Clin Obstet Gynecol. 2011;54:96–102.PubMedCrossRef Stuckey A. Breast cancer: epidemiology and risk factors. Clin Obstet Gynecol. 2011;54:96–102.PubMedCrossRef
4.
Zurück zum Zitat Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006;25:5898–905.PubMedCrossRef Antoniou AC, Easton DF. Models of genetic susceptibility to breast cancer. Oncogene. 2006;25:5898–905.PubMedCrossRef
5.
Zurück zum Zitat Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124:31–42.PubMedCrossRef Campeau PM, Foulkes WD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet. 2008;124:31–42.PubMedCrossRef
6.
Zurück zum Zitat Evans JP, Skrzynia C, Susswein L, Harlan M. Genetics and the young woman with breast cancer. Breast Dis. 2005;23:17–29.PubMed Evans JP, Skrzynia C, Susswein L, Harlan M. Genetics and the young woman with breast cancer. Breast Dis. 2005;23:17–29.PubMed
7.
Zurück zum Zitat Balmana J, Diez O, Rubio IT, Cardoso F. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol. 2011;22 Suppl 6:vi31–4.PubMed Balmana J, Diez O, Rubio IT, Cardoso F. BRCA in breast cancer: ESMO clinical practice guidelines. Ann Oncol. 2011;22 Suppl 6:vi31–4.PubMed
8.
Zurück zum Zitat Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.PubMedCrossRef Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.PubMedCrossRef
9.
Zurück zum Zitat He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.PubMedCrossRef He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.PubMedCrossRef
10.
Zurück zum Zitat Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–14.PubMedCrossRef Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–14.PubMedCrossRef
12.
Zurück zum Zitat Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065–70.PubMedCrossRef Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065–70.PubMedCrossRef
13.
Zurück zum Zitat Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature mir-125a alters the processing of pri-mirna. Hum Mol Genet. 2007;16:1124–31.PubMedCrossRef Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature mir-125a alters the processing of pri-mirna. Hum Mol Genet. 2007;16:1124–31.PubMedCrossRef
14.
Zurück zum Zitat Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.PubMedCentralPubMedCrossRef Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105:7269–74.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Chen J, Tian W, Cai H, He H, Deng Y. (2012) Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29:2527–2534 Chen J, Tian W, Cai H, He H, Deng Y. (2012) Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29:2527–2534
16.
Zurück zum Zitat Toyama T, Kondo N, Endo Y, Sugiura H, Yoshimoto N, et al. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol. 2012;42:256–63.PubMedCrossRef Toyama T, Kondo N, Endo Y, Sugiura H, Yoshimoto N, et al. High expression of microRNA-210 is an independent factor indicating a poor prognosis in Japanese triple-negative breast cancer patients. Jpn J Clin Oncol. 2012;42:256–63.PubMedCrossRef
17.
Zurück zum Zitat Wang C, Gao C, Zhuang JL, Ding C, Wang Y (2012) A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 138:2127–2136 Wang C, Gao C, Zhuang JL, Ding C, Wang Y (2012) A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 138:2127–2136
18.
Zurück zum Zitat Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, et al. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J Int Med Res. 2012;40:859–66.PubMedCrossRef Zhao FL, Hu GD, Wang XF, Zhang XH, Zhang YK, et al. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. J Int Med Res. 2012;40:859–66.PubMedCrossRef
19.
Zurück zum Zitat Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, et al. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PloS One. 2012;7:e39011.PubMedCentralPubMedCrossRef Zhou X, Marian C, Makambi KH, Kosti O, Kallakury BV, et al. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PloS One. 2012;7:e39011.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–4.PubMedCentralPubMedCrossRef Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005;436:740–4.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.PubMedCrossRef Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.PubMedCrossRef
22.
Zurück zum Zitat Esquela-Kerscher A, Slack FJ. OncomiRs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.PubMedCrossRef Esquela-Kerscher A, Slack FJ. OncomiRs—microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.PubMedCrossRef
23.
Zurück zum Zitat Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56:695–8.PubMedCrossRef Qiu LX, He J, Wang MY, Zhang RX, Shi TY, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56:695–8.PubMedCrossRef
24.
Zurück zum Zitat Xu W, Xu J, Liu S, Chen B, Wang X, et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PloS One. 2011;6:e20471.PubMedCentralPubMedCrossRef Xu W, Xu J, Liu S, Chen B, Wang X, et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PloS One. 2011;6:e20471.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Wang AX, Xu B, Tong N, Chen SQ, Yang Y, et al. Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Gen Mol Res: GMR. 2012;11:3051–62.CrossRef Wang AX, Xu B, Tong N, Chen SQ, Yang Y, et al. Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Gen Mol Res: GMR. 2012;11:3051–62.CrossRef
26.
Zurück zum Zitat Wang F, Sun G, Zou Y, Fan L, Song B. Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. PloS One. 2012;7:e39623.PubMedCentralPubMedCrossRef Wang F, Sun G, Zou Y, Fan L, Song B. Lack of association of miR-146a rs2910164 polymorphism with gastrointestinal cancers: evidence from 10206 subjects. PloS One. 2012;7:e39623.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Wang J, Bi J, Liu X, Li K, Di J, et al. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case–control studies. Mol Biol Rep. 2012;39:4571–9.PubMedCrossRef Wang J, Bi J, Liu X, Li K, Di J, et al. Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case–control studies. Mol Biol Rep. 2012;39:4571–9.PubMedCrossRef
28.
Zurück zum Zitat Wang J, Wang Q, Liu H, Shao N, Tan B, et al. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 2012;27:779–88.PubMedCrossRef Wang J, Wang Q, Liu H, Shao N, Tan B, et al. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis. 2012;27:779–88.PubMedCrossRef
29.
Zurück zum Zitat Lian H, Wang L, Zhang J. Increased risk of breast cancer associated with cc genotype of has-miR-146a rs2910164 polymorphism in Europeans. PloS One. 2012;7:e31615.PubMedCentralPubMedCrossRef Lian H, Wang L, Zhang J. Increased risk of breast cancer associated with cc genotype of has-miR-146a rs2910164 polymorphism in Europeans. PloS One. 2012;7:e31615.PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Wang F, Sun G, Zou Y, Li Y, Hao L, et al. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PloS One. 2012;7:e45042.PubMedCentralPubMedCrossRef Wang F, Sun G, Zou Y, Li Y, Hao L, et al. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PloS One. 2012;7:e45042.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Wang L, Qian S, Zhi H, Zhang Y, Wang B, et al. The association between Hsa-miR-499t>c polymorphism and cancer risk: a meta-analysis. Gene. 2012;508:9–14.PubMedCrossRef Wang L, Qian S, Zhi H, Zhang Y, Wang B, et al. The association between Hsa-miR-499t>c polymorphism and cancer risk: a meta-analysis. Gene. 2012;508:9–14.PubMedCrossRef
32.
Zurück zum Zitat Wang Y, Yang B, Ren X. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case–control studies. Gene. 2012;509:267–72.PubMedCrossRef Wang Y, Yang B, Ren X. Hsa-miR-499 polymorphism (rs3746444) and cancer risk: a meta-analysis of 17 case–control studies. Gene. 2012;509:267–72.PubMedCrossRef
33.
Zurück zum Zitat Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PloS One. 2012;7:e50887.PubMedCentralPubMedCrossRef Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PloS One. 2012;7:e50887.PubMedCentralPubMedCrossRef
34.
35.
Zurück zum Zitat Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.PubMedCrossRef
36.
Zurück zum Zitat Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–37.PubMedCrossRef Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–37.PubMedCrossRef
37.
Zurück zum Zitat Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA : J Am Med Assoc. 2006;295:676–80.CrossRef Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA : J Am Med Assoc. 2006;295:676–80.CrossRef
38.
Zurück zum Zitat Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, et al. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.PubMedCentralPubMedCrossRef Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, et al. MicroRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res. 2009;69:5970–7.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009;30:79–84.PubMedCrossRef Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009;30:79–84.PubMedCrossRef
40.
Zurück zum Zitat Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.PubMedCrossRef Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010;31:E1052–7.PubMedCrossRef
41.
Zurück zum Zitat Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R. Association between Hsa-miR-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis. 2010;31:2124–6.PubMedCrossRef Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R. Association between Hsa-miR-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis. 2010;31:2124–6.PubMedCrossRef
42.
Zurück zum Zitat Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat. 2010;121:693–702.PubMedCrossRef Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat. 2010;121:693–702.PubMedCrossRef
43.
Zurück zum Zitat Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in Hsa-miR-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet Off J Int Soc Twin Stud. 2011;14:417–21.CrossRef Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in Hsa-miR-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet Off J Int Soc Twin Stud. 2011;14:417–21.CrossRef
44.
Zurück zum Zitat Zhang P (2011) Polymorphisms of microRNA and ESR1 genes and their association with triple negative breast cancer risk and prognosis. Ph.D. thesis, Beijing Union Medical College Zhang P (2011) Polymorphisms of microRNA and ESR1 genes and their association with triple negative breast cancer risk and prognosis. Ph.D. thesis, Beijing Union Medical College
45.
Zurück zum Zitat Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PloS One. 2012;7:e30049.PubMedCentralPubMedCrossRef Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PloS One. 2012;7:e30049.PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall’olio V, et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat. 2012;133:805–7.PubMedCrossRef Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall’olio V, et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat. 2012;133:805–7.PubMedCrossRef
47.
Zurück zum Zitat Linhares JJ, Azevedo Jr M, Siufi AA, de Carvalho CV, Wolgien MD, et al. Evaluation of single nucleotide polymorphisms in microRNAs (Hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet. 2012;13:119.PubMedCentralPubMedCrossRef Linhares JJ, Azevedo Jr M, Siufi AA, de Carvalho CV, Wolgien MD, et al. Evaluation of single nucleotide polymorphisms in microRNAs (Hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet. 2012;13:119.PubMedCentralPubMedCrossRef
48.
Zurück zum Zitat Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, et al. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 2012;9:115–8.PubMed Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, et al. A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genomics Proteomics. 2012;9:115–8.PubMed
49.
Zurück zum Zitat Zhang M, Jin M, Yu Y, Zhang S, Wu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care. 2012;21:274–80.CrossRef Zhang M, Jin M, Yu Y, Zhang S, Wu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care. 2012;21:274–80.CrossRef
50.
Zurück zum Zitat Chen T, Li Z, Yan J, Yang X, Salminen W. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis. 2012;27:59–66.PubMedCrossRef Chen T, Li Z, Yan J, Yang X, Salminen W. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis. 2012;27:59–66.PubMedCrossRef
51.
52.
Zurück zum Zitat Landi D, Gemignani F, Landi S. Role of variations within microRNA-binding sites in cancer. Mutagenesis. 2012;27:205–10.PubMedCrossRef Landi D, Gemignani F, Landi S. Role of variations within microRNA-binding sites in cancer. Mutagenesis. 2012;27:205–10.PubMedCrossRef
54.
Zurück zum Zitat Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, et al. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women’s Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res. 2011;13:R114.PubMedCentralPubMedCrossRef Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, et al. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women’s Environment, Cancer, and Radiation Epidemiology (WECARE) Study. Breast Cancer Res. 2011;13:R114.PubMedCentralPubMedCrossRef
55.
Zurück zum Zitat Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–68.PubMedCrossRef Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–68.PubMedCrossRef
56.
Zurück zum Zitat Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–7.PubMedCrossRef Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39:673–7.PubMedCrossRef
57.
Zurück zum Zitat Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. Hsa-miR-196a2 rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case–control studies. PloS One. 2011;6:e18108.PubMedCentralPubMedCrossRef Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. Hsa-miR-196a2 rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case–control studies. PloS One. 2011;6:e18108.PubMedCentralPubMedCrossRef
58.
Zurück zum Zitat Gao LB, Bai P, Pan XM, Jia J, Li LJ, et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;125:571–4.PubMedCrossRef Gao LB, Bai P, Pan XM, Jia J, Li LJ, et al. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2011;125:571–4.PubMedCrossRef
59.
Zurück zum Zitat Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. Mir-196a2c allele is a low-penetrant risk factor for cancer development. Cytokine. 2011;56:589–92.PubMedCrossRef Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. Mir-196a2c allele is a low-penetrant risk factor for cancer development. Cytokine. 2011;56:589–92.PubMedCrossRef
60.
Zurück zum Zitat Tian T, Xu Y, Dai J, Wu J, Shen H, et al. Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet. 2010;1:358–66.PubMedCentralPubMed Tian T, Xu Y, Dai J, Wu J, Shen H, et al. Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet. 2010;1:358–66.PubMedCentralPubMed
61.
Zurück zum Zitat Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:269–75.PubMedCrossRef Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:269–75.PubMedCrossRef
62.
Zurück zum Zitat Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, Barnes D, et al (2011) The rs2910164:G>c snp in the mir146a gene is not associated with breast cancer risk in brca1 and brca2 mutation carriers. Human Mutat 32:1004–1007 Garcia AI, Cox DG, Barjhoux L, Verny-Pierre C, Barnes D, et al (2011) The rs2910164:G>c snp in the mir146a gene is not associated with breast cancer risk in brca1 and brca2 mutation carriers. Human Mutat 32:1004–1007
63.
Zurück zum Zitat Zhong S, Chen Z, Xu J, Li W, Zhao J (2013) Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 40:3181–3186 Zhong S, Chen Z, Xu J, Li W, Zhao J (2013) Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 40:3181–3186
64.
Zurück zum Zitat Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007;67:11001–11.PubMedCrossRef Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007;67:11001–11.PubMedCrossRef
65.
Zurück zum Zitat Guttilla IK, White BA. Coordinate regulation of foxo1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284:23204–16.PubMedCrossRef Guttilla IK, White BA. Coordinate regulation of foxo1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem. 2009;284:23204–16.PubMedCrossRef
66.
Zurück zum Zitat Ma Y, Yu S, Zhao W, Lu Z, Chen J. MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting sprouty2. Cancer Lett. 2010;298:150–8.PubMedCrossRef Ma Y, Yu S, Zhao W, Lu Z, Chen J. MiR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting sprouty2. Cancer Lett. 2010;298:150–8.PubMedCrossRef
67.
Zurück zum Zitat Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.PubMedCrossRef Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–42.PubMedCrossRef
Metadaten
Titel
Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis
verfasst von
Qiao-Hui Chen
Qing-Bing Wang
Bei Zhang
Publikationsdatum
01.01.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 1/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1074-7

Weitere Artikel der Ausgabe 1/2014

Tumor Biology 1/2014 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.